Reports - Therapeutic Drug Monitoring Market
HealthcareTherapeutic Drug Monitoring Market
Therapeutic Drug Monitoring Market Size & Share | Growth Analysis 2035 by Product (Consumables, Equipment) by Technology (Immunoassays, Chromatography-MS, Other Technologies) by Drug Class (Antiepileptic Drugs, Antiarrhythmic Drugs, Immunosuppressant Drugs, Antibiotic Drugs, Bronchodilator Drugs, Psychoactive Drugs, Other Drugs) by Therapeutic Area (Neurological Disorders, Cardiology, Infectious Diseases, Oncology, Other Therapeutic Areas) by Specimen (Blood, Saliva, Other Samples) by End User (Hospital Laboratories, Commercial & Private Laboratories, Other End Users) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Therapeutic Drug Monitoring Market - Segment Analysis
1. Overview
2. Global Therapeutic Drug Monitoring Market, 2021 - 2035 (USD Million)
3. Global Therapeutic Drug Monitoring Market - by Product
3.1. By Consumables
3.2. By Equipment
4. Global Therapeutic Drug Monitoring Market - by Technology
4.1. By Immunoassays
4.2. By Chromatography-MS
4.3. By Other Technologies
5. Global Therapeutic Drug Monitoring Market - by Drug Class
5.1. By Antiepileptic Drugs
5.2. By Antiarrhythmic Drugs
5.3. By Immunosuppressant Drugs
5.4. By Antibiotic Drugs
5.5. By Bronchodilator Drugs
5.6. By Psychoactive Drugs
5.7. By Other Drugs
6. Global Therapeutic Drug Monitoring Market - by Therapeutic Area
6.1. By Neurological Disorders
6.2. By Cardiology
6.3. By Infectious Diseases
6.4. By Oncology
6.5. By Other Therapeutic Areas
7. Global Therapeutic Drug Monitoring Market - by Specimen
7.1. By Blood
7.2. By Saliva
7.3. By Other Samples
8. Global Therapeutic Drug Monitoring Market - by End User
8.1. By Hospital Laboratories
8.2. By Commercial & Private Laboratories
8.3. By Other End Users
9. Global Therapeutic Drug Monitoring Market - by region
9.1. North America
9.2. Europe
9.3. Asia Pacific
9.4. Latin America
9.5. Middle East & Africa
10. Market comparative analysis
Chapter 4 North America Therapeutic Drug Monitoring Market - Segment Analysis
1. Overview
2. North America Therapeutic Drug Monitoring Market, 2021 - 2035 (USD Million)
3. North America Therapeutic Drug Monitoring Market - by Product
3.1. By Consumables
3.2. By Equipment
4. North America Therapeutic Drug Monitoring Market - by Technology
4.1. By Immunoassays
4.2. By Chromatography-MS
4.3. By Other Technologies
5. North America Therapeutic Drug Monitoring Market - by Drug Class
5.1. By Antiepileptic Drugs
5.2. By Antiarrhythmic Drugs
5.3. By Immunosuppressant Drugs
5.4. By Antibiotic Drugs
5.5. By Bronchodilator Drugs
5.6. By Psychoactive Drugs
5.7. By Other Drugs
6. North America Therapeutic Drug Monitoring Market - by Therapeutic Area
6.1. By Neurological Disorders
6.2. By Cardiology
6.3. By Infectious Diseases
6.4. By Oncology
6.5. By Other Therapeutic Areas
7. North America Therapeutic Drug Monitoring Market - by Specimen
7.1. By Blood
7.2. By Saliva
7.3. By Other Samples
8. North America Therapeutic Drug Monitoring Market - by End User
8.1. By Hospital Laboratories
8.2. By Commercial & Private Laboratories
8.3. By Other End Users
Chapter 5 Europe Therapeutic Drug Monitoring Market - Segment Analysis
1. Overview
2. Europe Therapeutic Drug Monitoring Market, 2021 - 2035 (USD Million)
3. Europe Therapeutic Drug Monitoring Market - by Product
3.1. By Consumables
3.2. By Equipment
4. Europe Therapeutic Drug Monitoring Market - by Technology
4.1. By Immunoassays
4.2. By Chromatography-MS
4.3. By Other Technologies
5. Europe Therapeutic Drug Monitoring Market - by Drug Class
5.1. By Antiepileptic Drugs
5.2. By Antiarrhythmic Drugs
5.3. By Immunosuppressant Drugs
5.4. By Antibiotic Drugs
5.5. By Bronchodilator Drugs
5.6. By Psychoactive Drugs
5.7. By Other Drugs
6. Europe Therapeutic Drug Monitoring Market - by Therapeutic Area
6.1. By Neurological Disorders
6.2. By Cardiology
6.3. By Infectious Diseases
6.4. By Oncology
6.5. By Other Therapeutic Areas
7. Europe Therapeutic Drug Monitoring Market - by Specimen
7.1. By Blood
7.2. By Saliva
7.3. By Other Samples
8. Europe Therapeutic Drug Monitoring Market - by End User
8.1. By Hospital Laboratories
8.2. By Commercial & Private Laboratories
8.3. By Other End Users
Chapter 6 Asia Pacific Therapeutic Drug Monitoring Market - Segment Analysis
1. Overview
2. Asia Pacific Therapeutic Drug Monitoring Market, 2021 - 2035 (USD Million)
3. Asia Pacific Therapeutic Drug Monitoring Market - by Product
3.1. By Consumables
3.2. By Equipment
4. Asia Pacific Therapeutic Drug Monitoring Market - by Technology
4.1. By Immunoassays
4.2. By Chromatography-MS
4.3. By Other Technologies
5. Asia Pacific Therapeutic Drug Monitoring Market - by Drug Class
5.1. By Antiepileptic Drugs
5.2. By Antiarrhythmic Drugs
5.3. By Immunosuppressant Drugs
5.4. By Antibiotic Drugs
5.5. By Bronchodilator Drugs
5.6. By Psychoactive Drugs
5.7. By Other Drugs
6. Asia Pacific Therapeutic Drug Monitoring Market - by Therapeutic Area
6.1. By Neurological Disorders
6.2. By Cardiology
6.3. By Infectious Diseases
6.4. By Oncology
6.5. By Other Therapeutic Areas
7. Asia Pacific Therapeutic Drug Monitoring Market - by Specimen
7.1. By Blood
7.2. By Saliva
7.3. By Other Samples
8. Asia Pacific Therapeutic Drug Monitoring Market - by End User
8.1. By Hospital Laboratories
8.2. By Commercial & Private Laboratories
8.3. By Other End Users
Chapter 7 Latin America Therapeutic Drug Monitoring Market - Segment Analysis
1. Overview
2. Latin America Therapeutic Drug Monitoring Market, 2021 - 2035 (USD Million)
3. Latin America Therapeutic Drug Monitoring Market - by Product
3.1. By Consumables
3.2. By Equipment
4. Latin America Therapeutic Drug Monitoring Market - by Technology
4.1. By Immunoassays
4.2. By Chromatography-MS
4.3. By Other Technologies
5. Latin America Therapeutic Drug Monitoring Market - by Drug Class
5.1. By Antiepileptic Drugs
5.2. By Antiarrhythmic Drugs
5.3. By Immunosuppressant Drugs
5.4. By Antibiotic Drugs
5.5. By Bronchodilator Drugs
5.6. By Psychoactive Drugs
5.7. By Other Drugs
6. Latin America Therapeutic Drug Monitoring Market - by Therapeutic Area
6.1. By Neurological Disorders
6.2. By Cardiology
6.3. By Infectious Diseases
6.4. By Oncology
6.5. By Other Therapeutic Areas
7. Latin America Therapeutic Drug Monitoring Market - by Specimen
7.1. By Blood
7.2. By Saliva
7.3. By Other Samples
8. Latin America Therapeutic Drug Monitoring Market - by End User
8.1. By Hospital Laboratories
8.2. By Commercial & Private Laboratories
8.3. By Other End Users
Chapter 8 Middle East & Africa Therapeutic Drug Monitoring Market - Segment Analysis
1. Overview
2. Middle East & Africa Therapeutic Drug Monitoring Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Therapeutic Drug Monitoring Market - by Product
3.1. By Consumables
3.2. By Equipment
4. Middle East & Africa Therapeutic Drug Monitoring Market - by Technology
4.1. By Immunoassays
4.2. By Chromatography-MS
4.3. By Other Technologies
5. Middle East & Africa Therapeutic Drug Monitoring Market - by Drug Class
5.1. By Antiepileptic Drugs
5.2. By Antiarrhythmic Drugs
5.3. By Immunosuppressant Drugs
5.4. By Antibiotic Drugs
5.5. By Bronchodilator Drugs
5.6. By Psychoactive Drugs
5.7. By Other Drugs
6. Middle East & Africa Therapeutic Drug Monitoring Market - by Therapeutic Area
6.1. By Neurological Disorders
6.2. By Cardiology
6.3. By Infectious Diseases
6.4. By Oncology
6.5. By Other Therapeutic Areas
7. Middle East & Africa Therapeutic Drug Monitoring Market - by Specimen
7.1. By Blood
7.2. By Saliva
7.3. By Other Samples
8. Middle East & Africa Therapeutic Drug Monitoring Market - by End User
8.1. By Hospital Laboratories
8.2. By Commercial & Private Laboratories
8.3. By Other End Users
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Thermo Fisher Scientific Inc.
2. Biomerieux SA
3. Abbott Laboratories
4. SEKISUI CHEMICAL CO. Ltd.
5. Danaher Corporation
6. F. Hoffmann-La Roche Ltd.
7. Siemens AG
8. Chromsystems Instruments & Chemicals GmbH
9. Exagen Inc.
10. Bio-Rad Laboratories Inc.
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By